NCT00513695 2019-08-07
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
University of Washington
Phase 2 Completed
Clinical Trials
4 trialsNCT00049114 2013-06-06
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00016406 2013-01-24
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed
NCT00005800 2012-09-25
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed